Table 3.
Ref. | Transfer Method | Blastocyst Development | Births Rate | Carry-Over | Notes |
---|---|---|---|---|---|
Tachibana et al., 2009 [19] | HVJ-E EF |
HVJ-E: 61% (45/74) similar to control EF: 9% (1/11) lower than control |
27% (4/15) 17% Similar to control |
ESCs and offspring: undetectable (<3%) | First animals born by MST Lower development to blastocyst due to premature oocyte activation |
Cheng et al., 2009 [27] | EF | Not indicated | Inter-strain: 26% Intra-strain: 34% Similar to control |
Not tested | GVT and PNT also performed |
Neupane et al., 2014 [28] | HVJ-E | PTGN: 82.6% (19/23) similar to control ICSI: 0% (0/12) similar to control |
Not tested | 0.29% ± 0.63% Undetectable in 17/24 |
Carry-over of MST, GVT, and PNT were compared |
Wang et al., 2014 [31] | HVJ-E | 85.7% (18/21) | 44.4% (8/18) | F1 tail: 5.5% ± 1.4% F2 fingers: 7.1% ± 6.8% |
First publication to propose polar bodies transfer |
All the works, except the Tachibana group (that was carried out in rhesus macaques), were performed in murine model. ESCs: embryonic stem cells. EF: electrofusion. F1/F2: mice of first and second generation. HVJ-E: extract of de Sendai virus. ICSI: intracytoplasmatic spermatozoid injection. PTGN: partenogenetically activated oocytes (without fertilization).